Anti-PEc: Development of a novel monoclonal antibody against prostate cancer.
Athanasios ArmakolasNektarios AlevizopoulosMartha StathakiConstantina PetrakiGeorge AgrogiannisMartina SamiotakiGeorge PanayotouEirini ChatzinikitaMichael KoutsilierisPublished in: British journal of cancer (2024)
These data indicate that the therapeutic targeting of PEc with the anti-PEc MAb may have considerable clinical benefit for prostate cancer patients.